Differentiating Arthritides: Understanding Clinical and Laboratory Findings

Arthritis is a common condition that affects the joints, and it can be challenging to distinguish between the various types that exist. However, by considering the patient’s medical history, physical examination, and laboratory findings, clinicians can make an accurate diagnosis.

For instance, psoriatic arthritis is an inflammatory subtype of arthritis that often affects the DIP joints, sausage digits, and nails. The classic X-ray finding of psoriatic arthritis is the pencil in a cup appearance, although it is not specific to the disease. In contrast, rheumatoid arthritis is characterized by PIP and MCP joint involvement, wrist and cervical spine pain, and positive rheumatoid factor and anti-CCP antibodies.

Septic arthritis is a medical emergency that usually involves large joints and is associated with high fever, chills, and rapid joint destruction. Synovial fluid analysis may reveal Gram-positive cocci in cases of septic arthritis caused by Staphylococcus aureus.

Osteoarthritis, on the other hand, is a degenerative joint disease that is associated with subchondral cyst formation, joint space narrowing, and osteophyte formation. It typically affects the DIP and PIP joints and large weight-bearing joints, but it is not an inflammatory arthritis.

In summary, understanding the clinical and laboratory findings associated with different types of arthritis is crucial for accurate diagnosis and appropriate management.

The Role of Human Leukocyte Antigens in Autoimmune Diseases

Human leukocyte antigens (HLAs) play a crucial role in the development of autoimmune diseases. Different HLAs are associated with specific autoimmune conditions. For example, HLA-B27 is present in 90% of patients with ankylosing spondylitis, as well as reactive arthritis and acute anterior uveitis. HLA-Cw6 is associated with psoriasis vulgaris, while HLA-B8 is linked to hyperthyroidism (Graves’ disease). HLA-DR4 is associated with rheumatoid arthritis and type 1 diabetes mellitus, and HLA-DR2 is linked to systemic lupus erythematosus (SLE) in Japanese people, multiple sclerosis, and Goodpasture syndrome. Understanding the role of HLAs in autoimmune diseases can help with diagnosis and treatment.

Common Organisms in Septic Arthritis

Septic arthritis is a serious condition that occurs when a joint becomes infected. The most common organism causing septic arthritis is Staphylococcus aureus. Pseudomonas spp can also cause septic arthritis, but it is less likely than S. aureus, especially in intravenous drug users. Escherichia coli is another pathogen that can cause septic arthritis, but it is less common than S. aureus. In children under the age of two, Haemophilus influenzae is the most common organism causing septic arthritis. Neisseria gonorrhoeae is a common cause of arthritis in the United States, but it is uncommon in Western Europe. It is important to identify the causative organism in order to provide appropriate treatment for septic arthritis.

The first-line treatment for ankylosing spondylitis is non-steroidal anti-inflammatories (NSAIDs) like ibuprofen, which should be used alongside physiotherapy and exercise. Long-term NSAID use requires gastro protection with a proton-pump inhibitor. If morning or night pain persists despite NSAIDs, a long-acting preparation can be tried. Tumour necrosis factor (TNF)-alpha inhibitors like etanercept are recommended for poorly controlled ankylosing spondylitis after NSAIDs. Methotrexate is only useful in cases with extensive peripheral joint involvement, which is not mentioned in the vignette. Oral steroids like prednisolone are not first-line management, but intra-articular corticosteroids may be considered for poorly controlled sacroiliitis. Sulfasalazine, a disease-modifying agent used in rheumatoid arthritis, is only useful in ankylosing spondylitis patients with peripheral joint involvement, which is not mentioned in the vignette.

When it comes to bone density, T scores are an important measure to understand. A T score of less than -2.5 is indicative of osteoporosis, while a T score between -1 and -2.5 suggests osteopenia. On the other hand, a T score of 0-1 is considered normal, but may still require monitoring. A T score greater than 2.5 is also normal, but may not be the case if the patient has experienced a fragility fracture. It’s important to note that Z scores, which take into account age and gender, can also provide insight into bone density. Understanding T scores and their implications can help healthcare professionals and patients take preventative measures to maintain bone health.

Treatment Options for Severe Rheumatoid Arthritis

Severe rheumatoid arthritis can be a challenging condition to manage, especially when conventional disease-modifying anti-rheumatic drugs (DMARDs) fail to provide relief. In such cases, biological therapies may be recommended. Here are some treatment options for severe rheumatoid arthritis:

Enrol in Biological Therapy Programme
Patients with highly active disease despite trying three previous agents for a therapeutic treatment duration may be candidates for biological treatments. TNF-alpha inhibitors and anti-CD20 are examples of biological treatments that are routinely used in the UK.

Maintain on Steroids and Add a Bisphosphonate
Short-term treatment with glucocorticoids may be offered to manage flares in people with recent-onset or established disease. However, long-term treatment with glucocorticoids should only be continued when the long-term complications of glucocorticoid therapy have been fully discussed and all other treatment options have been offered.

Commence Leflunomide
Severe disease that has not responded to intensive therapy with a combination of conventional DMARDs should be treated with biological agents. Leflunomide is one of the DMARDs that can be used in combination therapy.

Use Methotrexate/Leflunomide Combination
Patients who have not responded to intensive DMARD therapy may be prescribed a biological agent, as per NICE guidelines. Methotrexate and leflunomide are two DMARDs that can be used in combination therapy.

Avoid Commencing Penicillamine
DMARD monotherapy is only recommended if combination DMARD therapy is not appropriate. Patients without contraindications to combination therapy should not be prescribed penicillamine.

Differential Diagnosis for a Patient with Splenomegaly, Neutropenia, and Active Rheumatoid Disease

Felty’s Syndrome:
The patient’s symptoms of splenomegaly, neutropenia, and active rheumatoid disease suggest Felty’s syndrome. This condition is thought to occur due to the sequestration and destruction of granulocytes, potentially caused by reduced granulocyte growth factors and autoantibodies/immune complexes formed against them. Felty’s syndrome affects 1-3% of patients with rheumatoid arthritis and has a higher prevalence in females. Treatment typically involves the use of methotrexate as a disease-modifying anti-rheumatic drug, with splenectomy reserved as a last resort.

Lymphoma:
While lymphoma can present with lymphadenopathy, the absence of B-symptoms such as fever, night sweats, weight loss, or pruritus makes this diagnosis less likely in this case.

Myeloma:
Myeloma often presents with anaemia and bone pain, as well as hypercalcaemia. Serum and urine electrophoresis are important investigations for this condition.

Sarcoidosis:
Sarcoidosis commonly presents with respiratory symptoms such as wheeze, cough, and shortness of breath, as well as erythema nodosum and lymphadenopathy on examination. While the patient has a history of lower respiratory tract infections, her response to clarithromycin suggests an infective cause rather than sarcoidosis.

Tuberculosis:
The patient does not have any clinical features or risk factors for tuberculosis.

Autoantibodies and their Associated Diseases

Autoantibodies are antibodies produced by the immune system that mistakenly target and attack the body’s own tissues. Here are some common autoantibodies and the diseases they are associated with:

1. c-ANCA (antineutrophil cytoplasmic antibody): GPA, a necrotising small-vessel vasculitis that commonly affects the kidneys and lungs.

2. Antimitochondrial antibody: primary biliary cholangitis.

3. Anti Glomerular basement membrane antibody: Goodpasture’s syndrome, a rare autoimmune disease that affects the lungs and kidneys.

4. p-ANCA (perinuclear ANCA): Eosinophilic Granulomatosis with Polyangiitis (previously known as Churg–Strauss syndrome), a rare autoimmune disease that affects the blood vessels.

5. Anti-acetylcholine receptor antibody: myasthenia gravis, a neuromuscular disorder that causes muscle weakness and fatigue.

Understanding the association between autoantibodies and their associated diseases can aid in diagnosis and treatment.

Sites of Crystal Deposition in Pseudogout

Pseudogout is a condition characterized by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in various tissues of the body. The most common site of deposition is the synovial fluid, which can lead to joint inflammation and pain. However, CPPD crystals can also be deposited in other tissues such as cartilage, ligaments, tendons, and bursae.

Cartilage is another common site for CPPD crystal deposition, and pseudogout is also known as chondrocalcinosis. Deposition in the ligaments and tendons is possible but less common than in the synovium. Bursae deposition is also possible but less common than synovium deposition.

In summary, while CPPD crystals can be deposited in various tissues in pseudogout, the synovium is the most common site of deposition, followed by cartilage, ligaments, tendons, and bursae.

Understanding Reactive Arthritis and Differential Diagnosis

Reactive arthritis is a condition characterized by the presence of urethritis, arthritis, and conjunctivitis. It typically occurs 1-3 weeks after an initial infection, with Chlamydia trachomatis and Salmonella, Shigella, and Campylobacter being the most common causative agents. In addition to the classic triad of symptoms, patients may also experience keratoderma blennorrhagica and buccal and lingual ulcers.

When considering differential diagnoses, it is important to note that inflammatory arthritides can be seropositive or seronegative. Seronegative spondyloarthritides include ankylosing spondylitis, psoriatic arthritis, enteropathic arthritis, reactive arthritis, and gonococcal arthritis.

Gonococcal arthritis is a form of septic arthritis that typically affects a single joint and presents with a hot, red joint and systemic signs of infection. Ankylosing spondylitis, on the other hand, does not present with any clinical features in this patient. Enteropathic arthritis is associated with inflammatory bowel disease, which is less likely in a patient with a recent history of travel and diarrhea. Psoriatic arthritis is unlikely to present simultaneously with psoriasis in a young, previously healthy patient without any prior history of either condition.